| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0008 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |